Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
citric acid (1 trial)
heparin (liquaemin) (1 trial)
taurolidine (Defencath) (1 trial)
Catheter-Related Infections (Phase 3)
Communicable Diseases (Phase 3)
Infections (Phase 3)
Kidney Failure, Chronic (Phase 3)
Renal Insufficiency (Phase 3)
Trials (1 total)
Trial APIs (3 total)